EMAIL THIS PAGE TO A FRIEND

Neural regeneration research

Expression pattern of neuregulin-1 type III during the development of the peripheral nervous system.


PMID 25788922

Abstract

Neuregulin-1 type III is a key regulator in Schwann cell proliferation, committing to a myelinating fate and regulating myelin sheath thickness. However, the expression pattern of neuregulin-1 type III in the peripheral nervous system during developmental periods (such as the premyelinating stage, myelinating stage and postmyelinating stage) has rarely been studied. In this study, dorsal root ganglia were isolated from rats between postnatal day 1 and postnatal day 56. The expression pattern of neuregulin-1 type III in dorsal root ganglia neurons at various developmental stages were compared by quantitative real-time polymerase chain reaction, western blot assay and immunofluorescent staining. The expression of neuregulin-1 type III mRNA reached its peak at postnatal day 3 and then stabilized at a relative high expression level from postnatal day 3 to postnatal day 56. The expression of neuregulin-1 type III protein increased gradually from postnatal day 1, reached a peak at postnatal day 28, and then decreased at postnatal day 56. Immunofluorescent staining results showed a similar tendency to western blot assay results. Experimental findings indicate that the expression of neuregulin-1 type III in rat dorsal root ganglion was increased during the premyelinating (from postnatal day 2 to postnatal day 5) and myelinating stage (from postnatal day 5 to postnatal day 10), but remained at a high level in the postmyelinating stage (after postnatal day 10).

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

G5417
Glycine, PharmaGrade, Ajinomoto, EP, JP, USP, manufactured under appropriate GMP controls for Pharma or Biopharmaceutical production, suitable for cell culture
C2H5NO2
410225
Glycine, ACS reagent, ≥98.5%
C2H5NO2
G7126
Glycine, ReagentPlus®, ≥99% (HPLC)
C2H5NO2
50046
Glycine, BioUltra, for molecular biology, ≥99.0% (NT)
C2H5NO2
G8898
Glycine, for electrophoresis, ≥99%
C2H5NO2
76524
Glycine, certified reference material, TraceCERT®
C2H5NO2
G7403
Glycine, BioXtra, ≥99% (titration)
C2H5NO2
50049
Glycine, BioUltra, ≥99.0% (NT)
C2H5NO2
G8790
Glycine, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, ≥98.5%
C2H5NO2
50050
Glycine, ≥99.0% (NT)
C2H5NO2
50058
Glycine, tested according to Ph.Eur.
C2H5NO2
PHR1111
Glycine, Pharmaceutical Secondary Standard; Certified Reference Material
C2H5NO2
1295800
Glycine, United States Pharmacopeia (USP) Reference Standard
C2H5NO2
W328707
Glycine, 99%, FCC
C2H5NO2
94119
Glycine, analytical standard, for nitrogen determination according to Kjeldahl method
C2H5NO2
G0450000
Glycine, European Pharmacopoeia (EP) Reference Standard
C2H5NO2
82762
Methanol, analytical standard
CH4O
PHR1372
Methanol, Pharmaceutical Secondary Standard; Certified Reference Material
CH4O
1424109
Methyl alcohol, United States Pharmacopeia (USP) Reference Standard
CH4O
P1636
Phenobarbital
C12H12N2O3
P-008
Phenobarbital solution, 1 mg/mL in methanol, ampule of 1 mL, certified reference material
C12H12N2O3